Rozenman Mary M.
Officer at Aimmune Therapeutics, Inc.
- Sold, on record
- $6.7M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Mar 1, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Aimmune Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Aimmune Therapeutics, Inc.UnusualNov 4, 2016 2016
Sold 24,096 shares at $17.60 ($424k)
Rozenman Mary M., Officer
Sold 100% of holdings ($424k position)0 shares leftFiling
- 2 Form 4 sale Aimmune Therapeutics, Inc.UnusualJul 5, 2017 +243 days
Sold 45,060 shares at $20.85 ($939k)
Rozenman Mary M., Officer
Sold 99.7% of holdings ($942k position)129 shares left1.8x usual sizeFiling
- 3 Form 4 sale Aimmune Therapeutics, Inc.UnusualJul 17, 2017 +12 days
Sold 14,940 shares at $21.44 ($320k)
Rozenman Mary M., Officer
Sold 99.1% of holdings ($323k position)129 shares left0.5x usual sizeFiling
- 4 Form 4 sale Aimmune Therapeutics, Inc.UnusualSep 7, 2017 +52 days
Sold 30,000 shares at $22.50 ($675k)
Rozenman Mary M., Officer
Sold 99.6% of holdings ($678k position)129 shares left1.2x usual sizeFiling
- 5 Form 4 sale Aimmune Therapeutics, Inc.UnusualDec 26, 2017 +110 days
Sold 75,010 shares at $38.88 ($2.9M)
Rozenman Mary M., Officer
Sold 99.8% of holdings ($2.9M position)129 shares left2.7x usual sizeFiling
- 6 Form 4 sale Aimmune Therapeutics, Inc.UnusualJan 2, 2018 +7 days
Sold 6,591 shares at $37.11 ($245k)
Rozenman Mary M., Officer
Sold 98.1% of holdings ($249k position)129 shares left0.2x usual sizeFiling
- 7 Form 4 sale Aimmune Therapeutics, Inc.UnusualFeb 1, 2018 +30 days
Sold 6,592 shares at $35.36 ($233k)
Rozenman Mary M., Officer
Sold 98.1% of holdings ($238k position)129 shares left0.2x usual sizeFiling
- 8 Form 4 sale Aimmune Therapeutics, Inc.UnusualMar 1, 2018 +28 days
Sold 1,807 shares at $33.10 ($60k)
Rozenman Mary M., Officer
Sold 93.3% of holdings ($64k position)129 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2018 | Mar 5, 2018 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 1,807 | $60k | 93.3% | Unusual | SEC |
| Feb 1, 2018 | Feb 5, 2018 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 6,592 | $233k | 98.1% | Unusual | SEC |
| Jan 2, 2018 | Jan 4, 2018 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 6,591 | $245k | 98.1% | Unusual | SEC |
| Dec 26, 2017 | Dec 28, 2017 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 75,010 | $2.9M | 99.8% | Unusual | SEC |
| Sep 7, 2017 | Sep 11, 2017 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 30,000 | $675k | 99.6% | Unusual | SEC |
| Jul 17, 2017 | Jul 17, 2017 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 14,940 | $320k | 99.1% | Unusual | SEC |
| Jul 5, 2017 | Jul 6, 2017 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 45,060 | $939k | 99.7% | Unusual | SEC |
| Nov 4, 2016 | Nov 4, 2016 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 24,096 | $424k | 100.0% | Unusual | SEC |
| Oct 5, 2016 | Oct 7, 2016 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 25,000 | $420k | 100.0% | Unusual | SEC |
| Sep 8, 2016 | Sep 9, 2016 | Aimmune Therapeutics, Inc. | Officer | Form 4 sale | 30,000 | $504k | 100.0% | Unusual | SEC |